Agilon Health, Inc.

As of June 20, 2025, the market trend is mildly bearish due to bearish signals from weekly MACD and KST indicators, despite some mildly bullish daily moving averages, resulting in a moderate overall bearish sentiment.

Agilon Health, Inc. is a small-cap company in the Pharmaceuticals & Biotechnology industry, reporting net sales of $1.533 billion and a net profit loss of $2 million as of March 2025. Key metrics include a market cap of $869.30 million, a negative P/E ratio, and a dividend yield of 0.00%.

As of Jun 18, Agilon Health, Inc. has a market capitalization of 869.30 million, with net sales of 5,988.96 million and a net profit of -255.41 million over the latest four quarters.